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Abstract According to the hypothesis of Traub, also known
as the ‘formula of Traub’, postmortem values of glucose and
lactate found in the cerebrospinal fluid or vitreous humor are
considered indicators of antemortem blood glucose levels.
However, because the lactate concentration increases in the
vitreous and cerebrospinal fluid after death, some authors
postulated that using the sum value to estimate antemortem
blood glucose levels could lead to an overestimation of the
cases of glucose metabolic disorders with fatal outcomes, such
as diabetic ketoacidosis. The aim of our study, performed on
470 consecutive forensic cases, was to ascertain the advan-
tages of the sum value to estimate antemortem blood glucose
concentrations and, consequently, to rule out fatal diabetic
ketoacidosis as the cause of death. Other biochemical param-
eters, such as blood 3-beta-hydroxybutyrate, acetoacetate,
acetone, glycated haemoglobin and urine glucose levels, were
also determined. In addition, postmortem native CT scan,
autopsy, histology, neuropathology and toxicology were per-
formed to confirm diabetic ketoacidosis as the cause of death.
According to our results, the sum value does not add any
further information for the estimation of antemortem blood
glucose concentration. The vitreous glucose concentration
appears to be the most reliable marker to estimate antemortem
hyperglycaemia and, along with the determination of other
biochemical markers (such as blood acetone and 3-beta-
hydroxybutyrate, urine glucose and glycated haemoglobin),
to confirm diabetic ketoacidosis as the cause of death.
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Introduction
Diabetes mellitus is a chronic metabolic disease responsible for
many deaths [1]. Any intercurrent illness can disrupt the met-
abolic balance in diabetics, particularly in individuals with type
1 diabetes. The stress of infection, injury, surgery and even
emotional turmoil are associated with an enhanced release of
the counterregulatory hormones (glucagon, adrenaline, nor-
adrenaline, cortisol and growth hormone). Even relatively mild
illnesses, such as respiratory infections or gastrointestinal
upsets, can cause an increased secretion of counterregulatory
hormones, which increase hepatic glucose production, stimu-
late ketogenesis and induce a state of insulin resistance with
decreased peripheral glucose use. Hyperglycaemia followed by
ketosis commonly results when absolute or relative insulin
deficiency and unopposed action of counterregulatory hor-
mones coexist. Absolute insulin deficiency occurs in patients
with type 1 diabetes, whereas a relative insulin deficiency may
occur in patients with type 2 diabetes, who cannot increase their
endogenous insulin release in response to illness or stress [2–4].
Starting from the assumption that glucose is converted
into lactate after death and to eliminate the negative effect of
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postmortem glycolysis, Traub [5] proposed that antemortem
blood glucose concentration could be estimated by summing
the postmortem values of glucose and lactate found in the
cerebrospinal fluid. The basis of this hypothesis was the
assumption that two molecules of lactic acid are the final
product of postmortem glycolysis of one molecule of glucose
(‘formula of Traub’). Subsequent to Traub, other authors have
proposed the establishment of the sum values of glucose and
lactate in the vitreous humor and/or cerebrospinal fluid to
estimate antemortem blood glucose concentrations [1, 6–11].
More recently, other authors [12, 13] postulated that using
the sum value of glucose and lactate to estimate antemortem
glycaemia could lead to overestimations of the cases of glu-
cose metabolic disorders with fatal outcomes, such as diabetic
ketoacidosis. Thus, vitreous glucose concentration (individu-
ally considered) has been proposed to be the most reliable
marker to estimate antemortem blood glucose levels. Howev-
er, in a review of the literature concerning glucose metabolism
disorders and postmortem biochemistry, Hess et al. [14]
reasserted the postmortem biochemical evaluation of
glucose metabolism based on the combination of glu-
cose and lactate concentrations, especially when the
analyses are performed in the vitreous humor.
The aim of our study, which was performed on 470 con-
secutive forensic cases, was to evaluate the diagnostic accu-
racy of the sum values of glucose and lactate in the vitreous
humor or in cerebrospinal fluid to estimate antemortem blood
glucose levels and rule out fatal diabetic ketoacidosis as the
cause of death. To do this, we compared the sum values of
glucose and lactate with individually considered glucose lev-
els. In accordance with previous observations, we decided to
test whether fatal diabetic ketoacidosis could be accurately
suspected when vitreous glucose levels were higher than
10 mmol/l or the sum value was higher than 23.7 mmol/l (in
the vitreous humor) and 23.4 mmol/l (in the cerebrospinal
fluid). Other biochemical parameters, such as blood 3-beta-
hydroxybutyrate, acetoacetate, acetone, glycated haemoglo-
bin and urine glucose levels, were determined. Postmortem
native CT scan, autopsy, histology, neuropathology and
toxicology were also performed to confirm diabetic
ketoacidosis as the cause of death.
Materials and methods
Population
During 2008–2010, vitreous humor and cerebrospinal fluid
samples were systematically collected from consecutive de-
ceased subjects immediately after their arrival at the morgue
(1–12 h after death). Blood and urine samples were also
collected from the same cases during autopsy. In total, 470
cases were included in this study (315males and 155 females),
with a mean age of 61.4 years. The criteria for including cases
were postmortem interval, medical records and circumstances
of death. Samples from severely decomposed bodies and from
bodies with severe cranial destruction were rejected. Only
cases with both vitreous humor and cerebrospinal fluid were
considered. Diabetic and non-diabetic subjects were selected
for this study, which included 119 subjects (79 males and 40
females) with a previous diagnosis of diabetes mellitus (68
insulin-dependent) and 351 subjects (236 males and 115
females) with no history of diabetes mellitus based on
the medical records. Because the study samples originat-
ed from forensic practice and most of the deaths oc-
curred outside the hospital, data on antemortem glucose
levels shortly before death were not available.
Reference standard
In accordance with previous observations, diabetic ketoacido-
sis was determined to be the cause of death when vitreous
glucose concentrations were above 10 mmol/l and blood 3-
beta-hydroxybutyrate levels were higher than 2,500 μmol/l.
Other biochemical parameters, such as blood acetoacetate and
acetone, glycated haemoglobin and urine glucose levels, were
also determined. Glycated haemoglobin and urine glucose
concentrations were not considered as parameters necessary
to establish the diagnosis of diabetic ketoacidosis but were
measured to better characterise the metabolic profiles of dia-
betic ketoacidosis cases. Postmortem native CT scan, autopsy,
histology, neuropathology and toxicologywere also performed
to exclude other possible causes of death.
Index test
The formula of Traub in the vitreous humor and cerebrospi-
nal fluid was calculated by adding half of the lactate con-
centration value to the glucose concentration value.
Methods for sampling and laboratory analyses are described
in the following subsections.
Biological samples
Postmortem vitreous samples were collected by aspiration
using a sterile needle and syringe. Right and left vitreous
samples were collected through a scleral puncture at the
lateral canthus, aspirated from the centre of each eye, pooled
in the same syringe and mixed together. Cerebrospinal fluid
samples were collected by aspiration using a sterile needle
and a syringe by suboccipital puncture. After collection, the
vitreous humor and cerebrospinal fluid samples were imme-
diately centrifuged at 3,000×g for 15 min. The separated
supernatant was collected, stored in tubes containing sodium
fluoride and frozen at −20°C. No specimens were excluded
because of insufficient sample volume.
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Postmortem blood samples were collected by aspiration
with a sterile needle and a syringe from the femoral vein
during autopsy, typically performed 24–48 h after death.
The blood samples were stored in tubes containing sodium
fluoride and in tubes containing ethylenediaminetetraacetic
acid (EDTA) then frozen at −20°C. Postmortem urine sam-
ples were also collected by bladder aspiration during autopsy
(24–48 h after death), stored in tubes with no preservatives
and frozen at −20°C.
Laboratory analyses
Determination of glucose and lactate in the vitreous humor
and cerebrospinal fluid
Glucose and lactate in the vitreous humor and cerebrospinal
fluid were systematically determined by enzymatic assays
on a Dimension® Xpand® Plus Integrated Chemistry
System (Siemens Healthcare Diagnostics Inc., Deerfield,
IL, USA).
Determination of 3-β-hydroxybutyrate and acetoacetate
in the blood
Frozen samples of blood (stored in tubes containing sodium
fluoride) were thawed overnight at 4°C and deproteinized
with perchloric acid. Supernatant was used for analysis. 3-
β-hydroxybutyrate (3HB) and acetoacetate concentrations
were both determined by an enzymatic photometric method.
Determination of glycated haemoglobin
Glycated haemoglobin was determined on whole blood
samples (stored in tubes containing EDTA) by ion-
exchange high-performance liquid chromatography (Bio-
Rad D-10 Dual Program, Hercules, CA, USA).
Determination of glucose in urine
Glucose in urine was analysed on the Roche Modular P
clinical chemistry system (Roche glucose hexokinase meth-
od calibrated using manufacturer-supplied materials and
values).
Determination of acetone in blood
Blood acetone was systematically determined by the use of
headspace gas chromatography with flame ionisation detec-
tion on an Agilent 1888 headspace and a 6850 GC (Palo
Alto, CA, USA). The blood samples were incubated for
20 min at 80°C and then expanded to the GC column.
Analyses were performed on the blood samples stored in
tubes containing sodium fluoride.
Statistical methods
Receiver operating curves were traced for both methods
(glucose and sum value) and area under the curve (AUC)
was statistically compared. Differences of p<0.05 were
considered statistically significant. Sensitivity, specificity,
predicting values and the likelihood ratio (LR) were mea-
sured for glucose with a cut-off value of 10 mmol/l in the
vitreous humor and for the sum value of 23.7 mmol/l (in the
vitreous humor) and 23.4 mmol/l (in the cerebrospinal flu-
id). The LR was weighed by prevalence and a 95% confi-
dence interval (CI 95%) was reported. Linear regression was
used to verify the similarities of concentrations between
measures in the vitreous humor and cerebrospinal fluid.
Ethical aspects
Ethical aspects were discussed with the local ethics commit-
tee, and this study was authorised as a part of an investiga-
tion into medico-legal autopsies ordered by the judicial
authorities.
Results
In total, 470 cases were included in this study. We identified
12 cases of hypothermia, showing blood 3HB values rang-
ing from 2,350 to 6,700 μmol/l, vitreous glucose levels
lower than 3.0 mmol/l and no ethanol in the blood. We also
observed four cases of alcoholic ketoacidosis, which
revealed blood 3HB values ranging from 1,650 to
2,400 μmol/l and glucose levels in the vitreous humor and
cerebrospinal fluid lower than 3.0 mmol/l. All hypothermia
and alcoholic ketoacidosis cases showed glycated haemo-
globin levels lower than 6.5%. Blood 3HB determination
was performed in all cases of sudden death, suspected hypo-
thermia, suspected alcohol misuse-related death and suspected
glucose metabolic disorders (250 out of 470 cases).
Figure 1a illustrates the correlation between glucose con-
centrations in the vitreous humor and cerebrospinal fluid
(R200.978). The addition of lactate (Fig. 1b) and glucose
values (using the formula of Traub) decreased the correla-
tion between both samples (R200.608), suggesting that lac-
tate levels, but not glucose levels, are differently affected in
the vitreous humor and in cerebrospinal fluid after death.
Eleven cases out of 470 (Table 1) showed vitreous glu-
cose concentrations over 10.0 mmol/l. For eight of these
cases, diabetic ketoacidosis was determined to be the cause
of death (blood 3HB concentrations between 6,730 and
17,600 μmol/l, glycated haemoglobin levels over 10.6%,
urine glucose levels between 100 and 205 mmol/l, blood
acetone levels between 3,450 and 10,860 μmol/l and ace-
toacetate levels lower than 20 μmol/l in seven out of eight
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cases). In two other cases (cases 9 and 10), the causes of
death were determined to be global cardiac hypertrophy
with mitral–aortic valvulopathies (heart weight of 850 g)
and gastric haemorrhage with massive blood aspiration into
the airways. In both cases, pathological findings were asso-
ciated with a hyperglycaemic state, which was not consid-
ered to be the cause of death.
Eleven cases out of 470 (Table 1) showed glucose con-
centrations in the cerebrospinal fluid over 8 mmol/l. For
eight of these cases, diabetic ketoacidosis was determined
to be the cause of death. A concentration of 21 mmol/l of
glucose (Table 1 and Fig. 2) was found in one case of fatal
diabetic ketoacidosis (case 7) as well as in cases 9 and 10,
which presented a hyperglycaemic state associated with
other pathologies responsible for death.
Fatal diabetic ketoacidosis was ruled out for vitreous
humor glucose concentrations lower than 26 mmol/l and
sum values lower than 42 mmol/l. For both methods, the
AUC was 100% and no significant difference between both
methods could be observed (p01.000). However, using
standard cut-off values (Table 2), positive predictive values
were better for determining the cause of death using glucose
alone rather than the sum value.
Finally, we observed 11 out of 470 cases with cerebrospinal
fluid sum values over 23.4 mmol/l and glucose concentrations
lower than 3 mmol/l, which was not consistent with the
hypothesis of antemortem hyperglycaemia with fatal out-
come. Moreover, according to all our results (postmortem
native CT scan, autopsy, toxicology, histology, postmortem
biochemistry and neuropathology), in none of these cases was
the cause of death attributed to diabetic ketoacidosis.
Discussion
The aim of this study was to evaluate the diagnostic accu-
racy of the sum values of glucose and lactate in the vitreous
humor or cerebrospinal fluid for the postmortem biochemi-
cal evaluation of the glucose metabolism and to rule out
glucose metabolic disorders with fatal outcomes, such as
diabetic ketoacidosis. Therefore, we compared the sum val-
ues of glucose and lactate with individually considered
glucose concentrations.
Out of the 470 cases included in our study, 11 cases
revealed vitreous glucose levels higher than 10 mmol/l.
The diagnosis of diabetic ketoacidosis as the cause of death
was proposed in eight cases. In accordance with the results
of our investigations, antemortem hyperglycaemia could be
detected by measuring only glucose levels in the vitreous
humor or cerebrospinal fluid. Relying on a vitreous glucose
cut-off level at 10 mmol/l guarantees the exclusion of ante-
mortem hyperglycaemia with diabetic ketoacidosis (sensi-
tivity 100%, negative predictive value 100%, specificity
>95% and positive predictive value >70%). The results of
our study also indicated that using the sum value of glucose
and lactate for the postmortem biochemical evaluation of
glucose metabolism could lead to an overestimation of the
number of cases of antemortem glycaemia with fatal out-
comes. In fact, according to the formula of Traub, as well as
the limit of 23.4 mmol/l for the sum value in the cerebro-
spinal fluid, the cause of death would have been erroneously
linked to a glucose metabolic disorder in 15 cases. Among
these cases, 11 revealed glucose concentrations lower than
3 mmol/l, which is completely inconsistent with the
a Glucose  alone b Formula of Traub (Glucose + ½ lactate)      
Fig. 1 Relationship between concentrations in the vitreous humor and cerebrospinal fluid (CSF) samples for glucose alone (a) and formula of
Traub (b). R20coefficient of determination (proportion of shared variance)
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hypothesis of antemortem hyperglycaemia. Based on these
results, we concluded that the sum value is primarily com-
prised of glucose in situations of antemortem hyperglycemia
and of lactate in the other situations.
Initial studies on postmortem glycolysis and postmortem
blood glucose were performed by Hamilton–Paterson and
Johnson [15], Tonge and Wannan [16] and Fekete and
Kerenyi [17]. Glycolysis is thought to continue spontane-
ously after death, and blood glucose concentration falls
extremely rapidly. Furthermore, death may be preceded by
agonal processes and cardiopulmonary resuscitation, which
are often associated with the secretion or administration of
catecholamines. This results in further mobilisation of liver
glycogen and release of glucose into the blood circulation as
a counterbalancing phenomenon [18]. Due to the difficulty
interpreting postmortem blood glucose levels, other fluids
have been proposed as being more reliable in the estimation
of antemortem blood glucose concentrations, particularly
the cerebrospinal fluid and vitreous humor [19–24]. Inves-
tigation of the biochemical constituents of the vitreous hu-
mor have been periodically performed by several authors
[25–27]. However, the postmortem identification of hypo-
and hyperglycaemia still remains interesting subjects of
research. Coe [20, 21, 23, 28] demonstrated that there was
a consistent but variable decrease in vitreous glucose con-
centrations with increasing postmortem time in non-diabetic
individuals, whereas postmortem glycolysis had little effect
on the elevated vitreous glucose values of uncontrolled
diabetics. Given the assumption that glucose is converted
into lactate after death and to eliminate the negative effect of
postmortem glycolysis, Traub proposed that antemortem
blood glucose concentration could be estimated by combin-
ing the postmortem values of glucose and lactate found in
the cerebrospinal fluid. The basis of this hypothesis was the
assumption that two molecules of lactic acid are the final
product of the postmortem glycolysis of one molecule of
glucose [5]. Several authors following Traub have attempted
to define the diagnostic meaning of the sum values of
glucose and lactate in the cerebrospinal fluid and/or vitreous
humor to estimate antemortem blood glucose concentrations
and to investigate metabolic disorders in diabetics and alco-
hol misuse-related deaths [1, 6–11, 29, 30].
Karlovsek [6, 7] investigated glucose and lactate levels in
the vitreous humor and cerebrospinal fluid in a group of
diabetic individuals and in a control group and proposed that
vitreous glucose levels over 13 mmol/l (234 mg/dl) or
combined values of glucose and lactate in the vitreous
humor or cerebrospinal fluid greater than 23.7 mmol/
l (427 mg/dl) and 23.4 mmol/l (422 mg/dl), respectively,
could be an indicator of an antemortem hyperglycaemic
state with fatal outcome.
Zilg et al. [13] postulated that, after an initial drop of
vitreous glucose during the very early postmortem period,Ta
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glucose levels remained stable for an appreciable time after
death, whereas lactate levels (and consequently, the sum
value of glucose and lactate) rise with increasing postmor-
tem time. Hence, they concluded that vitreous glucose con-
centration alone was more appropriate than the sum value of
glucose and lactate in the estimation of antemortem blood
glucose concentrations. The authors emphasised that the
decrease in vitreous glucose is limited to the early postmor-
tem period, probably due to the residual metabolic activity
of the surviving hyalocytes and inner retinal cells. Subse-
quent to this phase, glucose levels remain stable. Moreover,
the authors postulated that the presence of lactate in the
vitreous humor could be due not only to the postmortem
metabolism of glucose, but other sources could also be
responsible for its formation and subsequent increased con-
centrations in the vitreous humor after death. Consequently,
the authors assumed that the sum value was primarily
comprised of lactate levels, which increase with postmortem
time and that vitreous humor glucose concentrations alone
should be used to estimate antemortem blood glucose con-
centrations. To corroborate their hypothesis, Zilg et al.
reported the results of a study performed on more than
3,000 cases in which no cases of diabetic deaths revealing
only high vitreous lactate levels were observed.
Herein, the results of the study are consistent with these
conclusions and indicate that the sum value of glucose and
lactate in the vitreous humor or cerebrospinal fluid does not
add any further information when estimating antemortem
blood glucose concentrations. Moreover, the use of the sum
value could lead to an overestimation of cases of glucose
disorders with fatal outcomes, such as diabetic ketoacidosis.
Thus, the vitreous glucose concentration appears to be the
most reliable marker to estimate antemortem blood glucose
concentrations. Its determination, together with the
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Fig. 2 Relationship between
diabetic ketoacidosis cases,
formula of Traub values and
glucose concentrations in the
vitreous humor and
cerebrospinal fluid. Round dots
correspond to outside values
(>95th percentile). DKA
diabetic ketoacidosis
Table 2 Diagnostic accuracy for ruling out diabetic ketoacidosis using glucose and lactate postmortem concentrations
Sensitivity% (CI 95%) Specificity% (CI 95%) Predictive values Likelihood ratios
Positive%
[TP/(TP + FP)]
Negative%
[TN/(TN + FN)]
Positive LR
(CI 95%)
Negative
LR (CI 95%)
Vitreous humor
Glucose alone
(>10 mmol/l)
100% (59.8 to 100) 99.4% (98.0 to 99.8) 72.7% (8/11) 100% (459/459) 2.7 (0.95 to 7.5) 0 (−)
Traub (>23.7 mmol/l) 100% (59.8 to 100) 98.9% (97.3 to 99.6) 61.5% (8/13) 100% (457/457) 1.6 (0.71 to 3.6) 0 (−)
CSF
Glucose alone
(>10 mmol/l)
100% (59.8 to 100) 99.6% (98.3 to 99.9) 80.0% (8/10) 100% (460/460) 4.0 (1.1 to 14.4) 0 (−)
Traub (>23.4 mmol/l) 100% (59.8 to 100) 95.7% (93.3 to 97.3) 28.6% (8/28) 100% (442/442) 0.4 (0.21 to 0.75) 0 (−)
CI 95% confidence interval 95%, CSF cerebrospinal fluid, FN false negative, FP false positive, LR likelihood ratio, TN true negative, TP true
positive
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measurements of other biochemical markers, such as blood
3HB and acetone, urine glucose and glycated haemoglobin,
can confirm diabetic ketoacidosis as the cause of death and
better characterise the metabolic profiles in these situations.
Finally, we concluded that the determination of acetoacetate
levels does not add any further information in order to
estimate the importance of ketonemia when glucose meta-
bolic disorders are associated with ketoacidosis.
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